CXCL13 News and Research

RSS
After SARS-CoV-2 infection, anti-chemokine antibodies correlate with better outcomes

After SARS-CoV-2 infection, anti-chemokine antibodies correlate with better outcomes

Novel proteomics approach predicts severe COVID-19 outcomes

Novel proteomics approach predicts severe COVID-19 outcomes

New combination of biomarkers can benefit patients with advanced bladder cancer

New combination of biomarkers can benefit patients with advanced bladder cancer

Scientists identify two genes that may play a role in prostate enlargement

Scientists identify two genes that may play a role in prostate enlargement

New point-of-care test accelerates diagnosis of Lyme neuroborreliosis

New point-of-care test accelerates diagnosis of Lyme neuroborreliosis

Inflammation plays causal role in neurologic changes associated with Lyme disease

Inflammation plays causal role in neurologic changes associated with Lyme disease

Researchers identify new targets for future CLL therapies

Researchers identify new targets for future CLL therapies

Calistoga Pharmaceuticals presents CAL-101 PI3K inhibitor data at European Hematology Association Congress

Calistoga Pharmaceuticals presents CAL-101 PI3K inhibitor data at European Hematology Association Congress